PD-L1/IDO Peptide Vaccine
UCDCC#290
Phase 1 mab active
Quick answer
PD-L1/IDO Peptide Vaccine for High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma is a Phase 1 program (mab) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active